What is Xencor's other commercial liabilities?

Xencor (XNCR) reported other commercial liabilities of $34.25M in Q1 2026.

How has Xencor's other commercial liabilities changed year-over-year?

Xencor's other commercial liabilities increased by 113.2% year-over-year, from $16.06M to $34.25M.

What is the long-term trend for Xencor's other commercial liabilities?

Over 5 years (2020 to 2025), Xencor's other commercial liabilities has grown at a 14.7% compound annual growth rate (CAGR), from $17.6M to $34.96M.

Xencor XNCR Other Commercial Liabilities

Other Commercial Liabilities at other companies

AmgenAMGN

——

Janux TherapeuticsJANX

——

AnaptysBio, Inc.ANAB

——

Inhibrx Biosciences, Inc.INBX

——

Summit TherapeuticsSMMT

——

MBX Biosciences, Inc.MBX

——

Other financials

Income statement

See full

Revenue$4.5M-86.2%

Operating income-$77.9M-80.3%

Net income-$128.9M-166%

EPS (diluted)-$1.71-159%

Balance sheet

See full

Cash & equivalents$14.2M-64.3%

Total debt$175.2M-21.2%

Total equity$515.6M-19.4%

Total assets$736.8M-18.6%

Cash flow

See full

Operating cash flow-$67.6M-317%

CapEx$610.0K-57.8%

Free cash flow-$68.2M-286%

Valuation

See full

Market cap$1.07B+76.3%

Enterprise value$1.23B+55.9%

P/S11×+6.2×

Profitability

See full

Operating margin-217.9%+425pp

Net margin-177.1%+16.5pp

FCF margin-194%+166pp

Returns & leverage

See full

Return on equity-29.8%-2.7pp

Debt / equity0.3×0.0×

Current ratio6.6×+0.7×

Where this comes from

Reported directly by Xencor in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xencor's other commercial liabilities?: Xencor (XNCR) reported other commercial liabilities of $34.25M in Q1 2026.
How has Xencor's other commercial liabilities changed year-over-year?: Xencor's other commercial liabilities increased by 113.2% year-over-year, from $16.06M to $34.25M.
What is the long-term trend for Xencor's other commercial liabilities?: Over 5 years (2020 to 2025), Xencor's other commercial liabilities has grown at a 14.7% compound annual growth rate (CAGR), from $17.6M to $34.96M.